A Comparative Study of Topical Mitomycin C, Cyclosporine, and Bevacizumab after Primary Pterygium Surgery
Shinyoung Hwang, Sangkyung Choi
Korean J Ophthalmol. 2015;29(6):375-381.   Published online 2015 Nov 25     DOI: https://doi.org/10.3341/kjo.2015.29.6.375
Citations to this article as recorded by Crossref logo
Nuevas Técnicas Quirúrgicas en Pterigión
Erick Hernandez-Bogantes, David Jimenez-Collado, Guillermo R. Vera Duarte, Andrew Olivo-Payne
Highlights of Ophthalmology.2023; 51(1S): 22.     CrossRef
New Surgical Techniques for Pterygium
Erick Hernandez-Bogantes, David Jimenez-Collado, Guillermo R. Vera Duarte, Andrew Olivo-Payne
Highlights of Ophthalmology.2023; 51(1E): 22.     CrossRef
Efficacy and safety of anti-vascular endothelial growth factor agents in the treatment of primary pterygium
Bowen Zhang, Xingmei Dong, Yi Sun
Frontiers in Medicine.2023;[Epub]     CrossRef
Doppelbilder bei einem 60-jährigen Patienten
Amine Maamri, Shady Suffo, Barbara Käsmann-Kellner, Berthold Seitz
Der Ophthalmologe.2022; 119(3): 304.     CrossRef
Surgical Techniques and Adjuvants for the Management of Pterygium
Ekta D. Patel, Michelle K. Rhee
Eye & Contact Lens: Science & Clinical Practice.2022; 48(1): 3.     CrossRef
Comparison of pterygium recurrence with and without using postsurgical topical cyclosporin a 0.05%: A randomized clinical trial
Yousef Alizadeh, Mitra Akbari, RezaSoltani Moghadam, Maryam Dourandeesh, Zahra Moravej
Journal of Current Ophthalmology.2022; 34(2): 208.     CrossRef
5-Fluorouracil in primary, impending recurrent and recurrent pterygium: Systematic review of the efficacy and safety of a surgical adjuvant and intralesional antimetabolite
Brendon W.H. Lee, Amitouj S. Sidhu, Ian C. Francis, Minas T. Coroneo
The Ocular Surface.2022; 26: 128.     CrossRef
Evaluating the Efficacy and Safety of Different Pterygium Surgeries: A Review of the Literature
Marcin Palewski, Agnieszka Budnik, Joanna Konopińska
International Journal of Environmental Research and Public Health.2022; 19(18): 11357.     CrossRef
Pterygium: an update on pathophysiology, clinical features, and management
Toktam Shahraki, Amir Arabi, Sepehr Feizi
Therapeutic Advances in Ophthalmology.2021; 13: 251584142110201.     CrossRef
Efficacy of bevacizumab in the treatment of pterygium: An updated meta-analysis of randomized controlled trials
Xin Zhang, Yaping Jiang, Qiangqiang Fu, Xiaoyan Zhang, Yihui Chen
International Immunopharmacology.2021; 98: 107921.     CrossRef
Recurrent pterygium – features of surgical treatment
Inna A. Riks, Sergey Yu. Astakhov, Sanasar S. Papanyan, Maggie B. Ezugbaya, Rafik Boutaba, Ivan A. Sokolov
Ophthalmology Reports.2020; 13(2): 101.     CrossRef
Evaluation of antimitotic and antiangiogenic effect of preoperative subconjunctival application of mitomycin C in primary pterygium: a randomized trial
Thiago Gonçalves dos Santos Martins, Ana Luiza Fontes de Azevedo Costa, Karina Mie Furuzawa, Roger Chammas, Milton Ruiz Alves
International Ophthalmology.2019; 39(11): 2435.     CrossRef
Practice Patterns in the Management of Primary Pterygium: A Survey Study
Enrique O. Graue-Hernandez, Andrea Córdoba, Aida Jimenez-Corona, Arturo Ramirez-Miranda, Alejandro Navas, Juan C. Serna-Ojeda, Mark J. Mannis
Cornea.2019; 38(11): 1339.     CrossRef
Interferon Alpha-2b Eye Drops Prevent Recurrence of Pterygium After the Bare Sclera Technique: A Single-Center, Sequential, and Controlled Study
Mingyang Yin, Hang Li, Yingnan Zhang, Honglei Dai, Fei Luo, Zhiqiang Pan
Cornea.2019; 38(10): 1239.     CrossRef
Safety of antivascular endothelial growth factor administration in the ocular anterior segment in pterygium and neovascular glaucoma treatment
Shi-tong Huang, Bi-shan Tian, Ou Xiao, Yong-juan Yang, Shi-you Zhou
Medicine.2018; 97(34): e11960.     CrossRef
Adjuvant Use of Cyclosporine A in the Treatment of Primary Pterygium: A Systematic Review and Meta-Analysis
Qing Zhang, Ning Bao, Kun Liang, Liming Tao
Cornea.2018; 37(8): 1000.     CrossRef
Efficacy and Safety of Bevacizumab in the Treatment of Pterygium: An Updated Meta-Analysis of Randomized Controlled Trials
Yi Sun, Bowen Zhang, Xiuhua Jia, Shiqi Ling, Juan Deng
Journal of Ophthalmology.2018; 2018: 1.     CrossRef
Overexpression of low-density lipoprotein receptors stimulated by vascular endothelial growth factor in fibroblasts from pterygium
Mengliang Wu, Jiajian Wang, Qianwei Zhang, Yan Wang, Liangliang Niu, Tingting Shao
Biomedicine & Pharmacotherapy.2017; 93: 609.     CrossRef
Cyclosporine A inhibits TGF-β2-induced myofibroblasts of primary cultured human pterygium fibroblasts
Sang Il Gum, Yeoun-Hee Kim, Jae-Chang Jung, Im Gyu Kim, Jun Seok Lee, Kyoo Won Lee, Young Jeung Park
Biochemical and Biophysical Research Communications.2017; 482(4): 1148.     CrossRef
Evaluation of the Additive Effect of Bevacizumab Eye Drops to Mitomycin C in Primary Pterygium
Sameh M Fouda
Advances in Ophthalmology & Visual System.2017;[Epub]     CrossRef
Inhibition of Pterygium Fibroblast Migration and Outgrowth by Bevacizumab and Cyclosporine A Involves Down-Regulation of Matrix Metalloproteinases-3 and -13
Yeoun-Hee Kim, Jae-Chang Jung, Sang Il Gum, Su-Bin Park, Jin Yeul Ma, Yong Il Kim, Kyoo Won Lee, Young Jeung Park, Helen Fillmore
PLOS ONE.2017; 12(1): e0169675.     CrossRef
Pterygium: etiology, pathogenesis, treatment
S. A. Malozhen, S. V. Trufanov, D. A. Krakhmaleva
Vestnik oftal'mologii.2017; 133(5): 76.     CrossRef
Cultivation and characterization of pterygium as an ex vivo study model for disease and therapy
Natasha Josifovska, Dóra Júlia Szabó, Richárd Nagymihály, Zoltán Veréb, Andrea Facskó, Ketil Eriksen, Morten C. Moe, Goran Petrovski
Contact Lens and Anterior Eye.2017; 40(5): 283.     CrossRef